Literature DB >> 26854781

Ischemic Necrosis of Upper Lip, and All Fingers and Toes After Norepinephrine Use.

Jin Yong Shin1, Si-Gyun Roh, Nae-Ho Lee, Kyung-Moo Yang.   

Abstract

A 68-year-old woman with necrosis of total finger, toe, and upper lip was requested by department of internal medicine. She was diagnosed with septic shock and treated with norepinephrine 10 days ago. Norepinephrine is an often-used medicine for normalizing blood pressure in septic shock patients. Norepinephrine stimulates adrenergic receptors, causing vasoconstriction and the rise of blood pressure. These peripheral vasoconstrictions sometimes lead to ischemic changes in end organs. In this case report, the authors describe ischemic necrosis of the upper lip and all fingers and toes after norepinephrine use in a patient in the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26854781     DOI: 10.1097/SCS.0000000000002463

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  4 in total

1.  Digital necrosis: a potential risk of high-dose norepinephrine.

Authors:  Rafael Daroca-Pérez; Miguel F Carrascosa
Journal:  Ther Adv Drug Saf       Date:  2017-06-05

2.  Management of vasopressor induced ischemia.

Authors:  Michael Livesey; Julio J Jauregui; Max C Hamaker; Raymond A Pensy; Christopher G Langhammer; W Andrew Eglseder
Journal:  J Orthop       Date:  2020-10-16

3.  Septic Shock following Prostate Biopsy: Aggressive Limb Salvage for Extremities after Pressor-Induced Ischemic Gangrene.

Authors:  Jocelyn Lu; Tammer Elmarsafi; Chrisovalantis Lakhiani; Sarah R Sher; Christopher Attinger; Karen K Evans
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-09-20

4.  Pedal Gangrene in a Patient with COVID-19 Treated with Prone Positioning and Extracorporeal Membrane Oxygenation.

Authors:  Amanda Siegel; Ammar Al Rubaiay; Andrew Adelsheimer; John Haight; Scott Gawlik; Alisha Oropallo
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.